FDA
approval
· 2014-04-15
FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
Summary
FDA approved a supplemental application for Excedrin Migraine GelTabs, a combination product of acetaminophen, aspirin, and caffeine, by Haleon US Holdings LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EXCEDRIN MIGRAINE GELTABS (ACETAMINOPHEN, ASPRIN, CAFFEINE)